株探米国株
エドガーで原本を確認する
false 0000065770 0000065770 2026-08-06 2026-08-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) August 6, 2026

 

MicroVision, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-34170   91-1600822

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

18390 NE 68th Street

Redmond, Washington 98052

(Address of principal executive offices) (Zip code)

 

(425) 936-6847

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
Common stock, par value $0.001 per share   MVIS   The NASDAQ Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

 

On August 6, 2026, MicroVision, Inc. issued a press release announcing its second quarter 2026 results. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(c) Exhibits.

 

Pursuant to the rules and regulations of the SEC, the attached exhibit is deemed to have been furnished to, but not filed with, the SEC.

 

  Exhibit No.   Description
  99.1   Press Release of MicroVision, Inc. dated August 6, 2026
  104   Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document)

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  MICROVISION, INC.
     
  By: /s/ Drew G. Markham
    Drew G. Markham
    Senior Vice President, General Counsel and Secretary

 

Dated: August 6, 2026

 

 

 

EX-99.1 2 ex99-1.htm EX-99.1

 

Exhibit 99.1

 

MicroVision Reports Second Quarter 2026 Results and Highlights Commercial Momentum Across Multiple Markets

 

Advancing Lidar 2.0 strategy with expanding customer engagements, new product launches, strengthened leadership team, improved cash burn guidance, and growing commercial pipeline

 

REDMOND, Wash. – August 6, 2026MicroVision, Inc. (NASDAQ: MVIS), a leader in advanced perception solutions for industrial, security and defense, and automotive applications, today announced its second quarter 2026 results and provided a business update highlighting continued execution of its Lidar 2.0 strategy.

 

Key Operational Highlights

 

Advanced the Company’s Lidar 2.0 strategy, expanding MicroVision’s position as a perception solutions provider serving industrial, security & defense, automotive, robotics, and autonomous aerial markets.

 

Launched the MOVIA™ Air product family, with several pre-launch partners, introducing both MOVIA™ Air and MOVIA™ Air Plus, purpose-built airborne perception solutions designed for drones, autonomous aircraft, and defense applications.

 

Signed a long-term development agreement with a leading construction and mining equipment OEM to integrate IRIS lidar into next-generation autonomous hauling vehicles, and bridge to integration of the Company’s next-gen HALO lidar.
     
 

Fulfilled increasing demand for active evaluations with customers spanning target markets, including with a leading AI company and hyperscaler for robotics and autonomous systems, a leading e-commerce company for aerial logistics and delivery, a defense contractor for mission-ready ground autonomy, and more.

 

Shipped IRIS and MOVIA sensors supporting customer programs across industrial automation, autonomous systems, aerospace, defense, and artificial intelligence applications.

 

Launched MicroVision Semiconductor, establishing an in-house semiconductor organization that expands the Company’s custom ASIC, mixed-signal IC and advanced imaging capabilities while supporting both internal product development and external customer programs.

 

Strengthened the executive leadership team with the appointments of James Byun as Chief Commercial Officer and Cara Klaer as Head of Marketing & Communications.

 

Improved full-year cash burn guidance to approximately $60 million, reflecting expected normalization in the second half of the year following non-recurring cash usage in the first half, with improvement due to continued operational discipline and acquisition synergies.

 

Completed a 1-for-15 reverse stock split, strengthening the Company’s capital markets position and supporting continued Nasdaq listing compliance.

 

 

 

 

“Our second quarter demonstrates that MicroVision has evolved into a commercially focused perception company with the products, technology, leadership and operational discipline needed to compete across multiple high-growth markets,” said Glen DeVos, Chief Executive Officer of MicroVision. “Our Lidar 2.0 strategy is translating into meaningful commercial momentum and a path to near-term and future revenue.”

 

“Our strategy is simple: deliver the right perception solutions at the right cost across multiple industries. We’re leveraging a common technology platform to address opportunities spanning industrial automation, security and defense, autonomous aerial systems, robotics and automotive. Every new customer, product and market reinforces the scalability of our business model and the trajectory of our revenue growth.”

 

Key Financial Highlights for Q2 2026

 

Revenue for the second quarter of 2026 was $1.5 million, compared to $0.2 million for the second quarter of 2025, primarily as a result of a greater volume of sensors shipped, as well as development revenue, during the second quarter of 2026.

 

Total operating expenses for the second quarter of 2026 were $24.9 million, compared to $14.1 million for the second quarter of 2025, with the increase primarily relating to costs stemming from the acquisitions, along with integration and consolidation activities, during the second quarter of 2026.

 

Net loss for the second quarter of 2026 was $36.9 million, or $1.66 per share, compared to a net loss of $14.2 million, or $0.84 per share, for the second quarter of 2025.

 

Per share amounts have been adjusted to reflect the 1-for-15 reverse stock split that became effective on August 1, 2026.

 

Adjusted EBITDA for the second quarter of 2026 was a $18.8 million loss, compared to a $11.2 million loss for the second quarter of 2025.

 

 

 

 

Cash used in operations in the second quarter of 2026 was $19.1 million, which includes non-recurring payments related to acquisition and consolidation activities, compared to cash used in operations in the second quarter of 2025 of $12.7 million.

 

The Company ended the second quarter of 2026 with $27.2 million in cash and cash equivalents, including investment securities, compared to $74.8 million at December 31, 2025.

 

As of June 30, 2026, the Company has access to $68.4 million of capital, subject to certain conditions, including $41.2 million under its existing ATM, or at-the-market, facility and expects future financing activities to support continued execution of its strategic plan.

 

Conference Call

 

MicroVision will host a conference call today at 4:30 p.m. Eastern Time to discuss second quarter 2026 financial results and provide a business update.

 

The live webcast can be accessed on the Investor Relations section of the Company’s website at www.microvision.com. A replay of the webcast will be available following the conclusion of the call.

 

About MicroVision

 

MicroVision is defining the next generation of lidar-based perception solutions for automotive, industrial, and security & defense markets. As the industry moves beyond proof of concept toward value, deployment, and commercialization, MicroVision delivers integrated hardware and software solutions designed for real-world performance, automotive-grade reliability, and economic scalability. With engineering centers in the U.S. and Germany, MicroVision leads the industry in depth and breadth of its portfolio, with both short- and long-range lidar solutions, featuring solid-state sensors with varying wavelengths, advanced sensor architectures, design-to-cost engineering, and open software solutions.

 

For more information, visit the Company’s website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc, and LinkedIn at https://www.linkedin.com/company/microvision/.

 

MicroVision, MAVIN, MOSAIK, MOVIA, IRIS, and SENTINEL are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.

 

 

 

 

Non-GAAP Information

 

To supplement MicroVision’s condensed financial statements presented in accordance with GAAP, the Company presents investors with the non-GAAP financial measures “adjusted EBITDA” and “adjusted Gross Profit.” Adjusted EBITDA consists of GAAP net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization; non-cash gains and losses; share-based compensation; restructuring costs; acquisition-related costs; and impairment charges. Adjusted Gross Profit is calculated as GAAP gross profit before share-based compensation expense, inventory write downs, and the amortization of acquired intangibles included in cost of revenue.

 

MicroVision believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management and investors regarding financial and business trends, provides consistency and comparability with MicroVision’s past financial reports, and facilitates comparisons with other companies in the Company’s industry, many of which use similar non-GAAP financial measures to supplement their GAAP results. Internally, management uses these non-GAAP measures when evaluating operating performance because the exclusion of the items described above provides an additional useful measure of the Company’s operating results and facilitates comparisons of the Company’s core operating performance against prior periods and its business objectives. Externally, the Company believes that adjusted EBITDA and adjusted Gross Profit are useful to investors in their assessment of MicroVision’s operating performance and the valuation of the Company.

 

Adjusted EBITDA and adjusted Gross Profit are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they do not reflect all of the costs associated with the operations of MicroVision’s business as determined in accordance with GAAP. The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from its non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent.

 

The Company compensates for limitations of the adjusted EBITDA measure by prominently disclosing GAAP net income (loss), which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted EBITDA.

 

Similarly for adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross profit which is the difference between Revenue and Cost of revenue, which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation by backing out share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.

 

 

 

 

Forward-Looking Statements

 

Certain statements contained in this release, including market position, expectations, and likelihood of success; opportunities for customer engagement and revenue; expense reduction; benefits of acquisitions and integration synergies; market position; product portfolio; product and manufacturing capabilities; transaction benefits; access to capital and capital-raising opportunities; and expected revenue, expenses and cash usage are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company’s SEC reports, including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.

 

Investor Relations Contact

 

Jeff Christensen

Darrow Associates Investor Relations

MVIS@darrowir.com

 

Media Contact

 

Heidi Davidson - For MicroVision

heidi@galvanizeworldwide.com

(914) 441-6862

 

 

 

 

MicroVision, Inc.

Consolidated Balance Sheets

(In thousands)

 

    June 30,     December 31,  
    2026     2025  
             
Assets                
Current assets                
Cash and cash equivalents   $ 27,208     $ 32,363  
Investment securities, available-for-sale     -       42,471  
Restricted cash, current     482       497  
Accounts receivable, net of allowances     915       47  
Inventory     3,660       745  
Other current assets     2,021       4,989  
Total current assets     34,286       81,112  
                 
Property and equipment, net     15,787       4,280  
Operating lease right-of-use assets     17,655       14,075  
Restricted cash, net of current portion     1,184       1,204  
Intangible assets, net     13,684       32  
Goodwill     3,677       -  
Other assets     2,334       2,416  
Total assets   $ 88,607     $ 103,119  
                 
Liabilities and shareholders’ equity                
Current liabilities                
Accounts payable   $ 5,876     $ 1,628  
Accrued liabilities     7,511       5,426  
Deferred revenue     253       -  
Derivative liability     7,050       -  
Notes payable     24,559       19,212  
Operating lease liabilities, current     5,119       3,481  
Finance lease liabilities, current     13       14  
Other current liabilities     43       388  
Total current liabilities     50,424       30,149  
                 
Warrant liability     380       1,875  
Operating lease liabilities, net of current portion     15,743       14,034  
Finance lease liabilities, net of current portion     17       27  
Other long-term liabilities     1,424       1,486  
Total liabilities     67,988       47,571  
                 
Commitments and contingencies                
Shareholders’ equity                
Common stock at par value     23       20  
Additional paid-in capital     1,039,358       1,012,121  
Accumulated other comprehensive income     737       669  
Accumulated deficit     (1,019,499 )     (957,262 )
Total shareholders’ equity     20,619       55,548  
Total liabilities and shareholders’ equity   $ 88,607     $ 103,119  

 

 

 

 

MicroVision, Inc.

Consolidated Statement of Operations

(In thousands, except per share data)

 

    Three months ended June 30,     Six months ended June 30,  
    2026     2025     2026     2025  
                         
Revenue   $ 1,473     $ 155     $ 2,408     $ 744  
                                 
Cost of revenue     831       716       1,403       1,266  
Gross profit (loss)     642       (561 )     1,005       (522 )
                                 
Research and development expense     15,702       7,658       30,147       15,061  
Sales, marketing, general and administrative expense     9,211       6,437       18,722       13,113  
Impairment loss on operating lease right-of-use assets     -       -       9       -  
Gain on disposal of fixed assets     (60 )     -       (168 )     -  
Total operating expenses     24,853       14,095       48,710       28,174  
                                 
Loss from operations     (24,211 )     (14,656 )     (47,705 )     (28,696 )
                                 
Interest expense     (5,480 )     (2,170 )     (8,233 )     (15,073 )
Unrealized gain (loss) on derivative liability     (8,035 )     1,952       (4,655 )     2,794  
Unrealized gain on warrant liability     891       803       1,495       2,564  
Realized loss on debt extinguishment     -       -       (3,083 )     (4,654 )
Bargain purchase gain     -       -       147       -  
Other income (expense)     73       (65 )     160       223  
                                 
Net loss before taxes   $ (36,762 )   $ (14,136 )   $ (61,874 )   $ (42,842 )
                                 
Income tax expense     (181 )     (93 )     (363 )     (166 )
                                 
Net loss   $ (36,943 )   $ (14,229 )   $ (62,237 )   $ (43,008 )
                                 
Net loss per share - basic and diluted   $ (1.66 )   $ (0.84 )   $ (2.90 )   $ (2.63 )
                                 
Weighted-average shares outstanding - basic and diluted     22,296       16,977       21,441       16,356  

 

 

 

 

MicroVision, Inc.

Consolidated Statements of Cash Flows

(In thousands)

 

    Six months ended June 30,  
    2026     2025  
             
Cash flows from operating activities                
Net loss   $ (62,237 )   $ (43,008 )
Adjustments to reconcile net loss to net cash used in operations:                
Depreciation and amortization     5,344       2,952  
Unrealized gain (loss) on derivative liability     4,655       (2,794 )
Unrealized gain on warrant liability     (1,495 )     (2,564 )
Loss on debt extinguishment     3,083       4,654  
Bargain purchase gain     (147 )     -  
Gain on disposal of fixed assets     (168 )     -  
Impairment of operating lease right-of-use assets     9       -  
Inventory write-downs     52       -  
Non-cash interest expense     -       7,325  
Amortization of debt discount and issuance costs on notes payable     8,219       7,723  
Share-based compensation expense     2,287       3,851  
Net accretion of premium on short-term investments     (81 )     (195 )
Change in:                
Accounts receivable     (868 )     822  
Inventory     833       (3,796 )
Other current and non-current assets     1,115       (210 )
Accounts payable     4,248       432  
Accrued liabilities     2,085       (275 )
Contract liabilities and other current liabilities     (92 )     (450 )
Operating lease liabilities     (2,409 )     (1,097 )
Other long-term liabilities     (21 )     (197 )
Net cash used in operating activities     (35,588 )     (26,827 )
                 
Cash flows from investing activities                
Sales of investment securities     42,528       22,402  
Purchases of investment securities     -       (19,326 )
Cash paid for business combination     (33,178 )     -  
Purchases of property and equipment     (448 )     (307 )
Net cash provided by investing activities     8,902       2,769  
                 
Cash flows from financing activities                
Principal payments under finance leases     (8 )     (6 )
Principal proceeds from notes payable, net of debt discount and issuance costs     20,624       -  
Net proceeds from issuance of common stock and warrants     769       43,289  
Net cash provided by financing activities     21,385       43,283  
                 
Effect of exchange rate changes on cash, cash equivalents, and restricted cash     111       319  
                 
Change in cash, cash equivalents, and restricted cash     (5,190 )     19,544  
Cash, cash equivalents, and restricted cash at beginning of period     34,064       56,247  
Cash, cash equivalents, and restricted cash at end of period   $ 28,874     $ 75,791  

 

The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of June 30, 2026 and 2025:

 

    June 30,     June 30,  
    2026     2025  
Cash and cash equivalents   $ 27,208     $ 74,094  
Restricted cash, current     482       76  
Restricted cash, net of current portion     1,184       1,621  
Cash, cash equivalents, and restricted cash   $ 28,874     $ 75,791  

 

 

 

 

MicroVision, Inc.

Reconciliation of GAAP to Non-GAAP Measures

(In thousands)

 

    Three months ended June 30,     Six months ended June 30,  
    2026     2025     2026     2025  
                         
Reconciliation of Non-GAAP Gross Profit:                                
Gross profit (loss)   $ 642     $ (561 )   $ 1,005     $ (522 )
Inventory related write-downs     25       -       52       -  
Amortization of acquired intangibles     -       217       -       434  
Adjusted Gross Profit   $ 667     $ (344 )   $ 1,057     $ (88 )
                                 
Reconciliation of Non-GAAP Loss:                                
GAAP Net loss   $ (36,943 )   $ (14,229 )   $ (62,237 )   $ (43,008 )
Interest expense, net     5,407       2,235       8,073       14,850  
Provision for income taxes     181       93       363       166  
Depreciation and amortization     2,976       1,544       5,344       2,952  
Unrealized (gain) loss on derivative liability     8,035       (1,952 )     4,655       (2,794 )
Unrealized gain on warrant liability     (891 )     (803 )     (1,495 )     (2,564 )
Loss on debt extinguishment     -       -       3,083       4,654  
Gain on disposal of fixed assets     (60 )     -       (168 )     -  
Impairment of operating lease right-of-use assets     -       -       9       -  
Share-based compensation expense     1,304       1,930       2,287       3,851  
Inventory related write-downs     25       -       52       -  
Acquisition-related costs     1,143       -       2,870       -  
Restructuring charges     -       -       1,139       -  
Adjusted EBITDA   $ (18,823 )   $ (11,182 )   $ (36,025 )   $ (21,893 )